Malin (MLLNF) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Malin Corporation PLC has successfully sold its entire stake in CG Oncology for approximately €28.5 million, securing a 175% return on investment. The company plans to conduct a capital return to shareholders through a tender offer in the fourth quarter of 2024, with an estimated intrinsic equity value per share of €6.60 as of July 23, 2024. Malin’s current cash balance stands at €62.4 million following the divestiture.
For further insights into MLLNF stock, check out TipRanks’ Stock Analysis page.
